Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000336966 | SCV000330618 | pathogenic | not provided | 2018-07-10 | criteria provided, single submitter | clinical testing | The R902X pathogenic variant in the EHMT1 gene has not been reported previously as a pathogenic variant nor as a benign variant to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R902X variant is not observed in large population cohorts (Lek et al., 2016). Additionally, the R902X variant has occurred de novo in this individual, as well as in two other unrelated individuals with features consistent with Kleefstra syndrome tested at GeneDx. Therefore, this variant is considered pathogenic. |
3billion | RCV001808728 | SCV002058486 | pathogenic | Kleefstra syndrome 1 | 2022-01-03 | criteria provided, single submitter | clinical testing | Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). The variant has been reported to be associated with EHMT1 related disorder (ClinVar ID: VCV000280682). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Laboratory of Human Genetics, |
RCV001808728 | SCV002060419 | pathogenic | Kleefstra syndrome 1 | 2019-10-16 | criteria provided, single submitter | research | ACMG: PVS1, PS2, PM2, PP3, and PP5 |
Invitae | RCV001808728 | SCV004458735 | pathogenic | Kleefstra syndrome 1 | 2023-04-17 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 280682). This variant has not been reported in the literature in individuals affected with EHMT1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg902*) in the EHMT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EHMT1 are known to be pathogenic (PMID: 16826528, 19264732). |